Literature DB >> 30976932

The Epidemiology of Hepatocellular Carcinoma in the USA.

Hyun-Seok Kim1, Hashem B El-Serag2,3.   

Abstract

PURPOSE OF REVIEW: To discuss current knowledge and recent findings regarding the epidemiology of hepatocellular carcinoma (HCC) in the USA. RECENT FINDING: The US incidence rate of HCC is increasing, although the pace may have somewhat slowed since 2010. In 2012, incidence rates of HCC in Hispanics surpassed those of Asians. The recent epidemiological changes in major risk factors for HCC include increasing hepatitis C virus post-sustained virologic response, suppressed hepatitis B virus on nucleoside analogues, and alcoholic and non-alcoholic fatty liver disease. Non-alcoholic fatty liver disease has the greatest proportion of the burden of the main risk factors for HCC in the USA, followed by alcoholic liver disease, and hepatitis C virus and hepatitis B virus infections. This review focuses on current knowledge regarding the recent epidemiological trends in HCC, with an emphasis on future directions.

Entities:  

Keywords:  Epidemiology; Hepatocellular carcinoma; Prevention

Mesh:

Year:  2019        PMID: 30976932     DOI: 10.1007/s11894-019-0681-x

Source DB:  PubMed          Journal:  Curr Gastroenterol Rep        ISSN: 1522-8037


  41 in total

Review 1.  Immune Checkpoint Inhibitors in Hepatocellular Cancer: Current Understanding on Mechanisms of Resistance and Biomarkers of Response to Treatment.

Authors:  Amblessed E Onuma; Hongji Zhang; Hai Huang; Terence M Williams; Anne Noonan; Allan Tsung
Journal:  Gene Expr       Date:  2020-04-27

2.  Tumor Vascular Networks Depicted in Contrast-Enhanced Ultrasound Images as a Predictor for Transarterial Chemoembolization Treatment Response.

Authors:  Ipek Oezdemir; Corrine E Wessner; Colette Shaw; John R Eisenbrey; Kenneth Hoyt
Journal:  Ultrasound Med Biol       Date:  2020-06-16       Impact factor: 2.998

3.  The Evolving Landscape of Hepatocellular Carcinoma : A US Safety Net Collaborative Analysis of Etiology of Cirrhosis.

Authors:  Rachel M Lee; Adriana C Gamboa; Michael K Turgeon; Adam Yopp; Emily L Ryon; Joshua P Kronenfeld; Neha Goel; Annie Wang; Ann Y Lee; Sommer Luu; Cary Hsu; Eric Silberfein; Shishir K Maithel; Maria C Russell
Journal:  Am Surg       Date:  2020-07-28       Impact factor: 0.688

Review 4.  Abbreviated MRI for Hepatocellular Carcinoma Screening and Surveillance.

Authors:  Julie Y An; Miguel A Peña; Guilherme M Cunha; Michael T Booker; Bachir Taouli; Takeshi Yokoo; Claude B Sirlin; Kathryn J Fowler
Journal:  Radiographics       Date:  2020 Nov-Dec       Impact factor: 5.333

Review 5.  Molecular classification of hepatocellular carcinoma: prognostic importance and clinical applications.

Authors:  Aroosha Raja; Farhan Haq
Journal:  J Cancer Res Clin Oncol       Date:  2021-10-08       Impact factor: 4.553

6.  Intensity Modulated Proton Therapy for Hepatocellular Carcinoma: Initial Clinical Experience.

Authors:  Ronik S Bhangoo; Trey C Mullikin; Jonathan B Ashman; Tiffany W Cheng; Michael A Golafshar; Todd A DeWees; Jedediah E Johnson; Satomi Shiraishi; Wei Liu; Yanle Hu; Kenneth W Merrell; Michael G Haddock; Sunil Krishnan; William G Rule; Terence T Sio; Christopher L Hallemeier
Journal:  Adv Radiat Oncol       Date:  2021-03-02

7.  Computed Tomography-Derived Liver Surface Nodularity and Sarcopenia as Prognostic Factors in Patients with Resectable Metabolic Syndrome-Related Hepatocellular Carcinoma.

Authors:  Martin Seror; Riccardo Sartoris; Christian Hobeika; Mohamed Bouattour; Valérie Paradis; Pierre-Emmanuel Rautou; Olivier Soubrane; Valérie Vilgrain; François Cauchy; Maxime Ronot
Journal:  Ann Surg Oncol       Date:  2020-09-23       Impact factor: 5.344

8.  The Heterogeneity of Liver Cancer Metabolism.

Authors:  Javier Salazar; Anne Le
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

9.  Short chain fatty acids delay the development of hepatocellular carcinoma in HBx transgenic mice.

Authors:  Noreen McBrearty; Alla Arzumanyan; Eugene Bichenkov; Salim Merali; Carmen Merali; Mark Feitelson
Journal:  Neoplasia       Date:  2021-05-01       Impact factor: 5.715

10.  Irreversible electroporation enhances immunotherapeutic effect in the off-target tumor in a murine model of orthotopic HCC.

Authors:  Xiaoju Shi; Conor O'Neill; Xingtong Wang; Yujia Chen; Youxi Yu; Min Tan; Guoyue Lv; Yan Li; Robert C Martin
Journal:  Am J Cancer Res       Date:  2021-06-15       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.